Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0178 | ||||
Gene Name | SLC25A19 | ||||
Protein Name | Mitochondrial thiamine pyrophosphate carrier | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | DNC; MCPHA; MUP1; Mitochondrial uncoupling protein 1; SLC25A19; Solute carrier family 25 member 19; THMD3; THMD4; TPC | ||||
DT Family | Mitochondrial Carrier (MC) Family ; | ||||
Tissue Specificity | Expressed in all tissues examined except forplacenta. Highest levels in colon, kidney, lung, testis, spleen,and brain. | ||||
Function | This transporter is mitochondrial transporter mediating uptake of thiamine pyrophosphate (ThPP) into mitochondria. | ||||
Endogenous Substrate(s) | dNDPs; dNTPs | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Thiamine | EM Info | Identified using miR-155 Knockout MCF7 cells | [1] | ||
References | |||||
1 | Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett. 2015 Feb 28;357(2):488-97. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.